ResearchBlinatumomab nonresponse correlates with poor survival after brexucabtagene autoleucel in B-cell ALL
ResearchPredictors of complete molecular response and impact of allogeneic hematopoietic stem cell transplantation in Ph+ ALL (COMMAND)
ResearchGilteritinib for Prevention of Post-transplant Relapse in Patients With Acute Myeloid Leukemia and FLT3-ITD Mutation
ResearchEfficacy of bispecific T-cell engagers after CAR T-cell therapy failure in aggressive large B-cell lymphoma
ResearchHigher Cumulative Cytarabine Consolidation Improves Survival in Older Adults with Acute Myeloid Leukemia
ResearchA novel severe toxicity-free, and progression-free survival endpoint predicts outcomes after CD19 chimeric antigen receptor-T cell therapy in large B-cell lymphoma
ResearchsMAdCAM-1 is decreased after allo-HCT, along with gut microbiota dysbiosis, and is associated with hematopoietic recovery
ResearchChimeric antigen receptor T cell therapy in octogenarians with B cell lymphoma: a real-world US multicenter study
ResearchOutcomes With Venetoclax 50 mg, Hypomethylating Agents, and Voriconazole or Posaconazole in AML
ResearchReal-World Evidence of Treatment-Free Remission Strategies and Outcomes in Chronic Myeloid Leukemia
ResearchOutcomes with intensive chemotherapy, compared to hypomethylating agent + venetoclax, in patients with AML
ResearchTreatment of Diffuse Large B-cell Lymphoma Progressing or Relapsing after Chimeric Antigen Receptor T-cell Therapy
ResearchEfficacy of eltrombopag for treatment of thrombocytopenia in the setting of allogeneic hematopoietic cell transplantation